Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth ...
Illumina and Labcorp expand collaboration to advance precision oncology through innovative applications of NGS solutions: San Diego Friday, March 20, 2026, 15:00 Hrs [IST] Illumin ...
Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded ...
I don't ever intend to have another colonoscopy.
March 17 (Reuters) - Lantheus Holdings said on Tuesday that the U.S. health regulator has extended its review of the ...
The FDA has previously granted fast track designation to aglatimagene plus valacyclovir in combination with ICI therapy for ...
A LAMP-based, visually read assay enables rapid FSHR N680S genotyping from buccal swabs, potentially allowing pre-cycle ...
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S.
A Diaceutics report looks at when in the diagnosis, testing, and treatment process NSCLC patients lose out on access to precision medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results